Company Revenue

The company grew in the mid-single digits in the second quarter of 2025 and now has a full arsenal of...

The company drove high-single-digit growth in the second quarter of 2025 and plans to focus more on enabling technology innovation....

Excluding contributions from newly-acquired Nevro, Globus grew in the low single digits for the second quarter and first half of...

The company grew in the high single digits in the second quarter of 2025, with a significant portion of growth...

The company grew in the mid-single-digits amid steadily improving performance, operations and new product uptake....

The company grew in the low-single-digits as its completes a distributor transition but had notable wins in trauma and bone...

The company continued its market-leading growth as it seeks to meaningfully reduce the complexity and variability of spine surgery....

MACI continued its impressive growth with strong business fundamentals, while MACI Arthro is gearing up to be a major growth...

Excluding its divested spinal implant business, Stryker's orthopedic sales grew double-digits in the second quarter of 2025....

The company's orthopedic business remains challenged by supply chain troubles, but BioBrace and foot and ankle have been bright spots....